The history of Viagra, originally marketed by copyright, presents a intricate case study for backers considering the drug sector. Despite its early success and impact of billions in revenue , the exclusivity lapse has opened the floodgates for alternative medications, significantly eroding profit opportunities. This transition raises questions abou